Evaluation of biomarkers for ulcerative colitis comparing two sampling methods: fecal markers reflect colorectal inflammation both macroscopically and on a cellular level

References

• Sands BE. From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation. Gastroenterology 2004;126:1518–32.
   PubMed Web of Science ®Google Scholar
• Neurath MF, Travis SP. Mucosal healing in inflammatory bowel diseases: a systematic review. Gut 2012;61:1619–35.
   PubMed Web of Science ®Google Scholar
• Saverymuttu SH, Camilleri M, Rees H, Lavender JP, Hodgson HJ, Chadwick VS. Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology, and fecal indium 111-granulocyte excretion. Gastroenterology 1986;90:1121–8.
   PubMed Web of Science ®Google Scholar
• Izzo RS, Witkon K, Chen AI, Hadjiyane C, Weinstein MI, Pellecchia C. Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis. Am J Gastroenterol 1992;87:1447–52.
   PubMed Web of Science ®Google Scholar
• Carlson M, Raab Y, Sevéus L, Xu SY, Hällgren R, Venge P. Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis. Gut 2002;50:501–6.
   PubMed Web of Science ®Google Scholar
• Peterson CGB, Eklund E, Taha Y, Raab Y, Carlson M. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease. Am J Gastroenterol 2002;97:1755–62.
   PubMed Web of Science ®Google Scholar
• Ertekin V, Selimoglu MA, Turgut A, Bakan N. Fecal calprotectin concentration in celiac disease. J Clin Gastroenterol 2010;44:544–6.
   PubMed Web of Science ®Google Scholar
• Tibble J, Teahon K, Thjodleifsson B, Roseth A, Sigthorsson G, Bridger S, Foster R, Sherwood R, Fagerhol M, Bjarnason I. A simple method for assessing intestinal inflammation in Crohn’s disease. Gut 2000;47:506–13.
   PubMed Web of Science ®Google Scholar
• Peterson CG, Sangfelt P, Wagner M, Hansson T, Lettesjo H, Carlson M. Fecal levels of leukocyte markers reflect disease activity in patients with ulcerative colitis. Scand J Clin Lab Invest 2007;67:810–20.
   PubMed Web of Science ®Google Scholar
• Bischoff SC, Wedemeyer J, Herrmann A, Meier PN, Trautwein C, Cetin Y, Maschek H, Stolte M, Gebel M, Manns MP. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathol 1996;28:1–13.
   PubMed Web of Science ®Google Scholar
• Raab Y, Fredens K, Gerdin B, Hällgren R. Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents. Dig Dis Sci 1998;43:1061–70.
   PubMed Web of Science ®Google Scholar
• Levy AM, Gleich GJ, Sandborn WJ, Tremaine WJ, Steiner BL, Phillips SF. Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease. Mayo Clin Proc 1997;72:117–23.
   PubMed Web of Science ®Google Scholar
• Carlson M, Raab Y, Peterson C, Hällgren R, Venge P. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion. Am J Gastroenterol 1999;94:1876–83.
   PubMed Web of Science ®Google Scholar
• Lampinen M, Ronnblom A, Amin K, Kristjansson G, Rorsman F, Sangfelt P, Safsten B, Wagner M, Wanders A, Winqvist O, Carlson M. Eosinophil granulocytes are activated during the remission phase of ulcerative colitis. Gut 2005;54:1714–20.
   PubMed Web of Science ®Google Scholar
• Brynskov J, Nielsen OH, Ahnfelt-Ronne I, Bendtzen K. Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel disease (Crohn’s disease and ulcerative colitis): a review. Dig Dis 1994;12:290–304.
   PubMed Web of Science ®Google Scholar
• Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease – enhanced production during active disease. Gut 1990;31:686–9.
   PubMed Web of Science ®Google Scholar
• Carty E, De BM, Feakins RM, Rampton DS. Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper. Gut 2000;46:487–92.
   PubMed Web of Science ®Google Scholar
• Saiki T, Mitsuyama K, Toyonaga A, Ishida H, Tanikawa K. Detection of pro- and anti-inflammatory cytokines in stools of patients with inflammatory bowel disease. Scand J Gastroenterol 1998;33:616–22.
   PubMed Web of Science ®Google Scholar
• Wedrychowicz A, Stopyrowa J, Fyderek K, Miezynski W. Stool interleukin 1beta and interleukin 1 receptor antagonist concentrations in children with active ulcerative colitis and during recovery. Eur J Pediatr 2003;162:541–2.
   PubMed Web of Science ®Google Scholar
• Kolios G, Valatas V, Ward SG. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 2004;113:427–37.
   PubMed Web of Science ®Google Scholar
• Cross RK, Wilson KT. Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis 2003;9:179–89.
   PubMed Web of Science ®Google Scholar
• Rachmilewitz D, Eliakim R, Ackerman Z, Karmeli F. Direct determination of colonic nitric oxide level – a sensitive marker of disease activity in ulcerative colitis. Am J Gastroenterol 1998;93:409–12.
   PubMed Web of Science ®Google Scholar
• Kristjansson G, Venge P, Wanders A, Loof L, Hallgren R. Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome. Gut 2004;53:1806–12.
   PubMed Web of Science ®Google Scholar
• Binder V. A comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucosal exudate in ulcerative colitis. Scand J Gastroenterol 1970;5:627–32.
   PubMed Web of Science ®Google Scholar
• Lettesjo H, Hansson T, Peterson C, Ung KA, Ringstrom G, Abrahamsson H, Simren M. Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis. Scand J Gastroenterol 2006;41:54–9.
   PubMed Web of Science ®Google Scholar
• Kristjansson G, Hogman M, Venge P, Hallgren R. Gut mucosal granulocyte activation precedes nitric oxide production: studies in coeliac patients challenged with gluten and corn. Gut 2005;54:769–74.
   PubMed Web of Science ®Google Scholar
• Amin K, Ludviksdottir D, Janson C, Nettelbladt O, Bjornsson E, Roomans GM, Boman G, Seveus L, Venge P. Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group. Am J Respir Crit Care Med 2000;162:2295–301.
   PubMed Web of Science ®Google Scholar
• Travis SP, Higgins PD, Orchard T, Van Der Woude CJ, Panaccione R, Bitton A, O’Morain C, Panes J, Sturm A, Reinisch W, Kamm MA, D’haens G. Review article: defining remission in ulcerative colitis. Aliment Pharmacol Ther 2011;34:113–24.
   PubMed Web of Science ®Google Scholar
• Lundberg JO, Hellstrom PM, Lundberg JM, Alving K. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 1994;344:1673–4.
   PubMed Web of Science ®Google Scholar
• Reinders CA, Jonkers D, Janson EA, Stockbrugger RW, Stobberingh EE, Hellstrom PM, Lundberg JO. Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease. Scand J Gastroenterol 2007;42:1151–7.
   PubMed Web of Science ®Google Scholar
• Kristjansson G, Venge P, Hallgren R. Mucosal reactivity to cow’s milk protein in coeliac disease. Clin Exp Immunol 2007;147:449–55.
   PubMed Web of Science ®Google Scholar
• Kristjansson G, Serra J, Loof L, Venge P, Hallgren R. Kinetics of mucosal granulocyte activation after gluten challenge in coeliac disease. Scand J Gastroenterol 2005;40:662–9.
   PubMed Web of Science ®Google Scholar
• Liden M, Kristjansson G, Valtysdottir S, Venge P, Hallgren R. Cow’s milk protein sensitivity assessed by the mucosal patch technique is related to irritable bowel syndrome in patients with primary Sjogren’s syndrome. Clin Exp Allergy 2008;38:929–35.
   PubMed Web of Science ®Google Scholar
• Liden M, Kristjansson G, Valtysdottir S, Hallgren R. Gluten sensitivity in patients with primary Sjogren’s syndrome. Scand J Gastroenterol 2007;42:962–7.
   PubMed Web of Science ®Google Scholar
• Elliott SN, Wallace JL. Neutrophil-mediated gastrointestinal injury. Can J Gastroenterol 1998;12:559–68.
   PubMed Web of Science ®Google Scholar
• Ahrens R, Waddell A, Seidu L, Blanchard C, Carey R, Forbes E, Lampinen M, Wilson T, Cohen E, Stringer K, Ballard E, Munitz A, Xu H, Lee N, Lee JJ, Rothenberg ME, Denson L, Hogan SP. Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis. J Immunol 2008;181:7390–9.
   PubMed Web of Science ®Google Scholar
• Sangfelt P, Carlson M, Thörn M, Lööf L, Raab R. Neutrophil and eosinophil granule proteins as markers of response to local prednisolone treatment in distal ulcerative colitis and proctitis. Am J Gastroenterol 2001;96:1085–90.
   PubMed Web of Science ®Google Scholar
• Clarke K, Regueiro M. Stopping immunomodulators and biologics in inflammatory bowel disease patients in remission. Inflamm Bowel Dis 2012;18:174–9.
   PubMed Web of Science ®Google Scholar
• Rutter MD, Saunders BP, Wilkinson KH, Rumbles S, Schofield G, Kamm MA, Williams CB, Price AB, Talbot IC, Forbes A. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut 2004;53:1813–16.
   PubMed Web of Science ®Google Scholar